Purchases and Sales Made in Q4 2021 in Regencell Bioscience Holdings LTD (RGC)
This table provides information about the institutional ownership of Regencell Bioscience Holdings LTD (RGC) during Q4 2021. The information is specifically focused on institutions that hold shares of Regencell Bioscience Holdings Ltd.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 11, 2022
Q4 2021
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
6.82KNew |
$91.5K - $224K
|
6.82K
$34.9K
|
|
Feb 14, 2022
Q4 2021
|
Ubs Group Ag
|
BUY
|
- |
192New |
$2.58K - $6.31K
|
192
$983
|
|
Feb 07, 2022
Q4 2021
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Feb 14, 2022
Q4 2021
|
Morgan Stanley
New York, NY |
SELL
|
- |
-503Closed |
$6.76K - $16.5K
|
0
$0
|
|
Feb 14, 2022
Q4 2021
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-3.27KClosed |
$43.9K - $107K
|
0
$0
|
|
Feb 14, 2022
Q4 2021
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-10.2KClosed |
$137K - $335K
|
0
$0
|